Clinical Trials · NCT02146079
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 44
- Start date
- May 2014
- Locations
- 1 site, Japan
- Primary endpoint
- Area under the plasma semaglutide concentration-time curve